Technical Analysis for VRNA - Verona Pharma plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Buy Signal | Bullish | 3.82% | |
Spinning Top | Other | 3.82% | |
Lower Bollinger Band Walk | Weakness | 3.82% | |
Lower Bollinger Band Touch | Weakness | 3.82% | |
Oversold Stochastic | Weakness | 3.82% | |
New Downtrend | Bearish | 7.32% | |
Multiple of Ten Bullish | Other | 7.32% | |
Below Lower BB | Weakness | 7.32% | |
Lower Bollinger Band Touch | Weakness | 7.32% | |
Oversold Stochastic | Weakness | 7.32% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
10 DMA Resistance | about 2 hours ago |
Rose Above 10 DMA | about 4 hours ago |
Up 3% | about 4 hours ago |
Rose Above Previous Day's High | about 6 hours ago |
Up 2% | about 6 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/28/2023
Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The companys lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma. Verona Pharma plc is based in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Enzymes Respiratory Therapy Asthma Respiratory Diseases Pulmonary Disease Chronic Obstructive Pulmonary Disease Cystic Fibrosis Pulmonology Treatment Of Chronic Obstructive Pulmonary Disease Lactams Phosphodiesterase Bronchodilator
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Enzymes Respiratory Therapy Asthma Respiratory Diseases Pulmonary Disease Chronic Obstructive Pulmonary Disease Cystic Fibrosis Pulmonology Treatment Of Chronic Obstructive Pulmonary Disease Lactams Phosphodiesterase Bronchodilator
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 26.44 |
52 Week Low | 3.4078 |
Average Volume | 1,154,439 |
200-Day Moving Average | 10.70 |
50-Day Moving Average | 19.38 |
20-Day Moving Average | 22.66 |
10-Day Moving Average | 21.95 |
Average True Range | 1.53 |
RSI | 52.38 |
ADX | 23.35 |
+DI | 20.90 |
-DI | 16.55 |
Chandelier Exit (Long, 3 ATRs) | 21.74 |
Chandelier Exit (Short, 3 ATRs) | 24.26 |
Upper Bollinger Bands | 24.72 |
Lower Bollinger Band | 20.60 |
Percent B (%b) | 0.34 |
BandWidth | 18.16 |
MACD Line | 0.26 |
MACD Signal Line | 0.75 |
MACD Histogram | -0.4848 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 24.18 | ||||
Resistance 3 (R3) | 24.01 | 23.12 | 23.81 | ||
Resistance 2 (R2) | 23.12 | 22.57 | 23.20 | 23.69 | |
Resistance 1 (R1) | 22.56 | 22.22 | 22.84 | 22.73 | 23.57 |
Pivot Point | 21.67 | 21.67 | 21.81 | 21.75 | 21.67 |
Support 1 (S1) | 21.11 | 21.12 | 21.39 | 21.28 | 20.43 |
Support 2 (S2) | 20.22 | 20.77 | 20.30 | 20.31 | |
Support 3 (S3) | 19.66 | 20.22 | 20.19 | ||
Support 4 (S4) | 19.83 |